Riskpilot← Back to searchSign inGet full accessVeterinärvård på Lidingö AB
ABActiveOrg 5569280950Islinge Hamnväg 5Veterinary activities · NACE 7500Est. 20130 employees
Revenue 2024
SEK 813K
-15% vs 2023
EBITDA margin
-6.3%
-41% vs 2023
Equity ratio
14.4%
Financial strength
Net profit 2024
SEK -56K
-33% vs 2023
| Revenue | SEK 813K | -15% |
| EBITDA | SEK -51K | -41% |
| Net profit | SEK -56K | -33% |
| Total assets | SEK 236K | +21% |
| Equity | SEK 34K | -58% |
| Employees | 0 | — |
Legal name
Veterinärvård på Lidingö AB
Org number
5569280950
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
8 april 2013
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är att bedriva veterinärverksamhet och djursjukvård samt förebyggande djurhälsovård och rådgivning på djurklinik samt genom hembesök och därmed förenlig verksamhet.
Address
Islinge Hamnväg 5
Email
gustavrauschenbach@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 199 | 958 | 1 076 | 953 | 813 |
| Staff expenses | — | — | −554 | −452 | — |
| EBITDA | −6 | 74 | 33 | −36 | −51 |
| Depreciation & amort. | −6 | −6 | −6 | −6 | −6 |
| EBIT | −12 | 68 | 27 | −42 | −57 |
| Net financials | — | — | 0 | 0 | — |
| Profit before tax | −12 | 68 | 27 | −42 | −56 |
| Tax | −0 | −0 | — | — | −0 |
| Net profit | −12 | 68 | 27 | −42 | −56 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 379 | 269 | 339 | 195 | 236 |
| Equity | 88 | 156 | 182 | 80 | 34 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 291 | 114 | 157 | 115 | 202 |
| Total debt | 291 | 114 | 157 | 115 | 202 |
EBITDA margin
-6.3%
This company
15.8%
Market median
-140% vs market
20202024
Equity ratio
14.4%
This company
38.2%
Market median
-62% vs market
20202024
Return on equity
-164.7%
This company
18.4%
Market median
-995% vs market
20202024
Net profit margin
-6.9%
This company
8.1%
Market median
-185% vs market
20202024
Asset turnover
3.44×
This company
1.12×
Market median
+207% vs market
20202024
Debt / equity
5.94×
This company
0.62×
Market median
-858% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
JA Liquidator | Liquidator | 2025 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2025 | |
| Former (3) | ||
| Board of Directors | 2022 – 2025 | |
| Deputy Board Member | 2022 – 2024 | |
| Deputy Board Member | 2024 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NORS Invest AB
Veterinärvård på Lidingö AB Board members of Veterinärvård på Lidingö AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jill Anita Brodin | Liquidator | 0 companies |
| Gustav Eric Johan Rauschenbach | Board of Directors | 0 companies |
| Claes Gustaf Erik Abrahamsson | Board of Directors | 0 companies |
| Seija Anita Weinius | Deputy Board Member | 0 companies |
| Tor Ulf Erik Diderholm | Deputy Board Member | 0 companies |
| Sofia Eleonora Cobanov | Deputy Board Member | 0 companies |